Guardant Health (GH) Interest & Investment Income (2017 - 2026)

Guardant Health has disclosed Interest & Investment Income across 10 years of filings, most recently posting $11.2 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $11.2 million, up 22.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $36.1 million (down 24.62% YoY), and the FY2025 annual result was $34.1 million, down 36.5% from the prior year.
• Interest & Investment Income came in at $11.2 million for Q1 2026 at Guardant Health, up from $10.0 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $14.9 million in Q1 2024 to a low of $778000.0 in Q1 2022.
• The 5-year median for Interest & Investment Income is $9.1 million (2025), against an average of $8.3 million.
• Across the five-year window, Interest & Investment Income sank 49.84% in 2022 and soared 566.48% in 2023, its largest moves.
• Guardant Health's Interest & Investment Income stood at $2.2 million in 2022, then soared by 545.95% to $13.9 million in 2023, then declined by 16.09% to $11.7 million in 2024, then slipped by 13.91% to $10.0 million in 2025, then gained by 11.15% to $11.2 million in 2026.
• The last three Interest & Investment Income figures came in at $11.2 million (Q1 2026), $10.0 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.